British Journal of Cancer

Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.

Publisher
Nature Publishing Group
Country
United Kingdom
History
1947--present
Website
http://www.nature.com/bjc/index.html
Impact factor
6.176 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Medications

'Olive oil' drug shows early promise for some brain cancer patients

A unique drug derived from oleic acid—which naturally occurs in animal and vegetable fats such as olive oil—has shown promise for patients with an advanced form of the most common type of brain cancer, following a study ...

Medications

Aspirin may benefit cancer treatments

Aspirin is an inexpensive and readily available medication that could benefit cancer treatments, preventing metastatic cancer spread and reducing vascular complications, finds a new meta-analysis study.

page 1 from 23